We are pleased that the Abbott-Biogen Idec collaboration proceeds to make excellent improvement in advancing the development of a potential fresh MS therapy. Related StoriesExperimental drug shows guarantee in mice with multiple sclerosisPsychosocial elements linked to discomfort in multiple sclerosisGlobal life expectancy climbs, but people live longer with illnessesDAC HYP decreased the proportion of patients who relapsed by 55 % in the 150 mg group and by 51 % in the 300 mg group> SELECT also investigated the effect of DAC HYP on disability progression seeing that measured by the Expanded Disability Status Scale seeing that a tertiary endpoint.These reductions to the current quarter loss were partially offset by a $0.2 million upsurge in reduction from discontinued operations. Net loss for the fiscal yr 2010 was $7.3 million, or $0.19 per share, weighed against a net lack of $10.0 million, or $0.31 per share, for 2009. The lower net loss is primarily due to a royalty milestone payment of $2.5 million received in the first quarter of 2010. Money and cash equivalents as of December 31, 2010 were $2.1 million, weighed against $7.at December 31 6 million, 2009. The Company believes it has enough cash resources to invest in operations into May 2011 since it continues to defer certain discretionary activities.
An excellent nights sleep improves the memory According to a new study individuals who have an excellent nights sleep have better memories than people who sleep poorly.